openPR Logo
Press release

Inflammatory Bowel Disease Treatment Market Size worth USD 34.5 billion by 2031 | CAGR of 5.1%

03-30-2023 08:51 AM CET | Health & Medicine

Press release from: Allied Market Research (AMR)

Inflammatory Bowel Disease Drugs

Inflammatory Bowel Disease Drugs

Inflammatory Bowel Disease (IBD) treatment refers to the medical management of chronic inflammatory conditions that affect the gastrointestinal tract, including Crohn's disease and ulcerative colitis. IBD is characterized by chronic inflammation of the digestive tract, leading to symptoms such as abdominal pain, diarrhea, rectal bleeding, weight loss, and fatigue.

Allied Market Research has published a study report with the title Inflammatory Bowel Disease Drugs Market Size was Valued at USD 21.0 billion in 2021 and is Projected to Garner USD 34.5 billion by 2031, registering a CAGR of 5.1% from 2022 to 2031.

The report provides comprehensive information on the market trends, including insights on the top segments and key investment opportunities. The report also likely includes a detailed analysis of the value chains, regional landscape, and competitive scenario, which can be beneficial for businesses looking to expand their operations or enter a new market. Overall, the report appears to be a valuable resource for anyone seeking in-depth knowledge of the market dynamics and key factors driving its growth.

๐†๐ž๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐†๐ซ๐š๐ฉ๐ก๐ฌ ๐š๐ง๐ ๐…๐ข๐ ๐ฎ๐ซ๐ž๐ฌ ๐‡๐ž๐ซ๐ž: https://www.alliedmarketresearch.com/request-sample/4318

Rise in prevalence of ulcerative colitis and Crohn's disease, growing awareness of the disease across the world, increase in development of new drugs, increased government support for the management of inflammatory bowel disease drives the growth of the global inflammatory bowel disease treatment market. Based on type, the Crohn's disease segment is likely to maintain its dominance through 2031. Region wise, Asia-Pacific would exhibit the fastest CAGR during the forecast period.

๐“๐จ๐ฉ ๐ˆ๐ง๐Ÿ๐ฅ๐š๐ฆ๐ฆ๐š๐ญ๐จ๐ซ๐ฒ ๐๐จ๐ฐ๐ž๐ฅ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ

โ€ข AbbVie Inc.
โ€ข Bristol Myers Squibb
โ€ข Celltrion Healthcare
โ€ข Eli-Lilly
โ€ข Johnson & Johnson Services Inc.
โ€ข Merck & Co, Inc.
โ€ข Novartis AG
โ€ข Pfizer Inc.
โ€ข Takeda Pharmaceutical Company Ltd.
โ€ข UCB S.A.

๐ˆ๐ง๐Ÿ๐ฅ๐š๐ฆ๐ฆ๐š๐ญ๐จ๐ซ๐ฒ ๐๐จ๐ฐ๐ž๐ฅ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐œ๐š๐ง ๐›๐ž ๐๐จ๐ง๐ž ๐›๐š๐ฌ๐ž๐ ๐จ๐ง ๐ฌ๐ž๐ฏ๐ž๐ซ๐š๐ฅ ๐Ÿ๐š๐œ๐ญ๐จ๐ซ๐ฌ, ๐ข๐ง๐œ๐ฅ๐ฎ๐๐ข๐ง๐ :

The report offers a detailed segmentation of the global inflammatory bowel disease treatment market based on type, drug class, distribution channel, and region. The report provides an analysis of each segment and sub-segment with the help of tables and figures. This analysis helps market players, investors and new entrants in determining the sub-segments to be tapped on to achieve growth in the coming years.

By Type

โ€ข Ulcerative Colitis
โ€ข Crohns Disease

By Drug Class

โ€ข TNF inhibitors
โ€ข Corticosteroids
โ€ข Aminosalicylates
โ€ข JAK inhibitors
โ€ข Anti-integrin
โ€ข IL inhibitors
โ€ข Others

By Distribution Channel

โ€ข Hospital Pharmacy
โ€ข Drug Store and Retail Pharmacy
โ€ข Online Pharmacy

Based on region, North America accounted for the largest share in 2021, contributing to more than two-fifths of the global inflammatory bowel disease treatment market, and is likely to dominate the market during the forecasted timeframe.

However, Asia-Pacific is expected to exhibit the fastest CAGR of 6.6% during the forecast period. The research also analyzes the regions including Europe and LAMEA.

๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
https://www.alliedmarketresearch.com/purchase-enquiry/4318

Key Benefits For Stakeholders

โ€ข This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the inflammatory bowel disease drugs market analysis from 2021 to 2031 to identify the prevailing inflammatory bowel disease drugs market opportunity.
โ€ข The market research is offered along with information related to key drivers, restraints, and opportunities.
โ€ข Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
โ€ข In-depth analysis of the inflammatory bowel disease drugs market segmentation assists to determine the prevailing market opportunities.
โ€ข Major countries in each region are mapped according to their revenue contribution to the global market.
โ€ข Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
โ€ข The report includes the analysis of the regional as well as global inflammatory bowel disease drugs market trends, key players, market segments, application areas, and market growth strategies.

Our Market Research Solution Provides You Answer to Below Mentioned Question:

โ€ข Which are the driving factors responsible for the growth of market?
โ€ข Which are the roadblock factors of this market?
โ€ข What are the new opportunities, by which market will grow in coming years?
โ€ข What are the trends of this market?
โ€ข Which are main factors responsible for new product launch?
โ€ข How big is the global & regional market in terms of revenue, sales and production?
โ€ข How far will the market grow in forecast period in terms of revenue, sales and production?
โ€ข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โ€ข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โ€ข Which region has more opportunities?

By Region Outlook

โ€ข North America
(U.S., Canada, Mexico)
โ€ข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โ€ข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โ€ข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Top Trending Report:

โ€ข AT-Home Testing Market: https://www.alliedmarketresearch.com/at-home-testing-market-A31866
โ€ข Resuscitation Devices Market: https://www.alliedmarketresearch.com/resuscitation-devices-market-A11454
โ€ข Gene Therapy Market: https://www.alliedmarketresearch.com/gene-therapy-market
โ€ข 3D Cell Culture Market: https://www.alliedmarketresearch.com/3d-cell-cultures-market
โ€ข Molecular diagnostics market: https://www.alliedmarketresearch.com/molecular-diagnostics-market
โ€ข MRI Coils Market: https://www.alliedmarketresearch.com/mri-coils-market-A14839
โ€ข Digital PCR Market: https://www.alliedmarketresearch.com/digital-polymerase-chain-reaction-market
โ€ข Dental Equipment Market: https://www.alliedmarketresearch.com/dental-equipment-market

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Inflammatory Bowel Disease Treatment Market Size worth USD 34.5 billion by 2031 | CAGR of 5.1% here

News-ID: 2994233 • Views: โ€ฆ

More Releases from Allied Market Research (AMR)

Online Music Streaming Market Demand will reach a value of US$ 24,711.3 million by 2027 at a CAGR of 12.34%
Online Music Streaming Market Demand will reach a value of US$ 24,711.3 million โ€ฆ
The global online music streaming market size is expected to reach $24,711.3 million by 2027 at a CAGR of 12.34% from 2021 to 2027. Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/11521 Online music streaming is a means of delivering music without downloading any file from the internet. Music is stored on the servers' database and is instantly transferred to the streamer or users' device in realโ€ฆ
Low-E Glass Market Growth Trends: Global Analysis of Leading Players and Business Development Forecast to 2032
Low-E Glass Market Growth Trends: Global Analysis of Leading Players and Busines โ€ฆ
According to the study, the global low-e glass market was valued at $11.9 billion in 2022 and is projected to reach $21.0 billion by 2032, growing at a CAGR of 5.9% from 2023 to 2032. Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A15849 Market Drivers and Challenges: - The growing emphasis on energy efficiency and cost reduction is propelling the demand for low-emissivity (Low-E) glass globally. Despite higher upfront costs compared to traditional glass,โ€ฆ
Sunflower Lecithin Market: Industry Development Challenges, Opportunities & Key Manufacturers Analysis to 2032
Sunflower Lecithin Market: Industry Development Challenges, Opportunities & Key โ€ฆ
According to the report, the global sunflower lecithin market was valued at $324.6 million in 2018 and is projected to reach $754.8 million by 2032, growing at a CAGR of 5.7% from 2023 to 2032. Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A156654 What is Sunflower Lecithin? Sunflower lecithin is a natural lipid blend derived from sunflower seeds, either mechanically or chemically, and is prized for its superior emulsifying and stabilizing properties. Composed primarilyโ€ฆ
Bio-Renewable Chemicals Companies Analysis and Developments by 2031
Bio-Renewable Chemicals Companies Analysis and Developments by 2031
According to the report, the global bio-renewable chemicals market was valued at $2.5 billion in 2021 and is projected to reach $7.4 billion by 2031, registering a CAGR of 11.6% from 2022 to 2031. The study provides an in-depth analysis of market dynamics, emerging trends, key investment areas, value chains, regional insights, and competitive landscapes. Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/156 Market Drivers, Restraints, and Opportunities Drivers: - Technological advancements and innovations inโ€ฆ

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease โ€ฆ
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.โ€ฆ
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas โ€ฆ
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by theโ€ฆ
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind โ€ฆ
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohnโ€™s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcoholโ€ฆ
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, andโ€ฆ
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing geneโ€ฆ
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news andโ€ฆ